This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

Beta Site: This is a new site which is still under development. We welcome your feedback, which will help improve it.

Feedback form

Glossary

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • ECMCs

    Experimental Cancer Medicine Centres (ECMCs) act as an efficient and effective UK-wide network for delivering pioneering, early-phase cancer trials, bringing together world-leading laboratory and clinical researchers to test new treatments for adults and children with cancer.
  • Economic analysis

    Comparison of the relationship between costs and outcomes of alternative healthcare interventions.
  • Effect size

    A generic term for the estimate of treatment effect for a study.
  • Efficacy

    The extent to which an intervention produces a beneficial result under ideal conditions. Clinical trials that assess efficacy are sometimes called explanatory trials.
  • EME

    Efficacy and Mechanism Evaluation, one of the NIHR programmes. The EME Programme funds research which aims to establish definitive proof of clinical efficacy. Studies may also include embedded mechanistic studies which will add to our understanding of biological or behavioural mechanisms.
  • Epidemiology

    The study of population and community health, not just individuals.
  • Equipoise

    A state of uncertainty where a person believes it is equally likely that either of two treatment options is better.
  • Evaluative research

    Evaluative research seeks to assess or judge in some way, providing useful information about something which cannot be gleaned by mere observation or investigation of relationships.
  • Evidence synthesis

    Evidence synthesis involves the development of techniques to combine multiple sources of quantitative and qualitative data to derive best evidence for use in healthcare.
  • Experimental Cancer Medicine Centres

    Experimental Cancer Medicine Centres (ECMCs) act as an efficient and effective UK-wide network for delivering pioneering, early-phase cancer trials, bringing together world-leading laboratory and clinical researchers to test new treatments for adults and children with cancer.